Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Paul Kevin Wotton
Age : 59
Public asset : 1,507,832 USD
Linked companies : Vericel Corporation - Cynata Therapeutics Limited - PaxMedica, Inc.
Paul Kevin Wotton is a businessperson who founded Avenge Bio, Inc. and who has been at the helm of 6 different companies. Currently, he is Chief Executive Officer, President & Director at Obsidian Therapeutics, Inc.

He is also on the board of Vericel Corp., eXIthera Pharmaceuticals, Inc., Cynata Therapeutics Ltd. (former Chairman) and PaxMedica, Inc. and Member of Royal Pharmaceutical Society of Great Britain and Member of Licensing Executives Society.

Paul Kevin Wotton previously occupied the position of President, Chief Executive Officer & Director at Antares Pharma, Inc., Director at Sigilon Therapeutics, Inc., Operations Manager at Kelyniam Global, Inc., Chief Executive Officer of Topigen Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Astellas Institute for Regenerative Medicine, Head-Global Business Development at SkyePharma Plc, Vice President-Business Development for Penwest Pharmaceuticals Co., Vice President-Corporate Development for Eurand NV and Co-Chairman-Integration Management Office at Astellas Pharma US, Inc.

He received a doctorate from The University of Nottingham, an undergraduate degree from the University of London and an MBA from Kingston Business School.

Current positions of Paul Kevin Wotton 
NameTitle Since
Vericel Corporation
Independent Director 2015
Cynata Therapeutics Limited
(Biotechnology & Medical Research)
Independent Non-Executive Director 2020
PaxMedica, Inc.
(Biotechnology & Medical Research)
Independent Director 2020
eXIthera Pharmaceuticals, Inc. Director -
Obsidian Therapeutics, Inc. Chief Executive Officer, President & Director 2019
Royal Pharmaceutical Society of Great Britain Member -
Licensing Executives Society Member -

Holdings of Paul Kevin Wotton 
Vericel Corporation (VCEL)
26,6020.057%1,441,030 USD
Cynata Therapeutics Limited (CYP)
(Biotechnology & Medical Research)
175,7750.12%66,802 USD

Paul Kevin Wotton: Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
10/04ELON MUSK : Investors argue Musk should repay $9.4 billion to Tesla for SolarCity deal
10/12JACK MA : Billionaire Alibaba founder Jack Ma reappears in Hong Kong - sources
10/09ELON MUSK : First Berlin Teslas could come next month, Musk tells fans
10/03WARREN BUFFETT : Exclusive-Southwest Gas nears Questar deal after Buffett lost out-sources
10/06CARL ICAHN : Stock Futures Point to Fresh Selloff on Wall Street
More news

© 2021 People and Ownership :   
Paul Kevin Wotton : Connections